Advertisement

Topics

"Eisai with Oncology Group Biomedicine Doubles Down Boston" Drugs and Medication Database

01:37 EST 23rd February 2019 | BioPortfolio

Here are the most relevant "Eisai with Oncology Group Biomedicine Doubles Down Boston" Drugs and Medications that we have found in our database.

More Information about "Eisai with Oncology Group Biomedicine Doubles Down Boston" on BioPortfolio

We have published hundreds of Eisai with Oncology Group Biomedicine Doubles Down Boston news stories on BioPortfolio along with dozens of Eisai with Oncology Group Biomedicine Doubles Down Boston Clinical Trials and PubMed Articles about Eisai with Oncology Group Biomedicine Doubles Down Boston for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Eisai with Oncology Group Biomedicine Doubles Down Boston Companies in our database. You can also find out about relevant Eisai with Oncology Group Biomedicine Doubles Down Boston Drugs and Medications on this site too.

Showing "Eisai with Oncology Group Biomedicine Doubles Down Boston" Drugs and Medications, all 17

Probably Relevant

Halaven [eisai inc.]

These highlights do not include all the information needed to use HALAVEN safely and effectively. See full prescribing information for HALAVEN.         HALAVEN (eribulin mesylate) injection, for intravenous use Initial U.S. Approval: 2010

Possibly Relevant

Hexalen [eisai inc.]

Hexalen

Panretin [eisai inc.]

Panretin gel

Aloxi [eisai inc.]

These highlights do not include all the information needed to use ALOXI safely and effectively. See full prescribing information for ALOXI. ALOXI (palonosetron HCl) Injection for Intravenous Use Initial U.S. Approval: 2003

Fludeoxyglucose f-18 [brigham and women`s hospital, inc., the ]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxyglucose F18 Injection Initial U.S. Approval: 2005

Belviq [eisai inc.]

These highlights do not include all the information needed to use BELVIQ / BELVIQ XR safely and effectively. See full prescribing information for BELVIQ / BELVIQ XR .    BELVIQ (lorcaserin hydrochloride) tablets, for oral use, CIV BELVIQ XR (lorcaserin

Aricept [eisai inc.]

These highlights do not include all the information needed to use ARICEPT safely and effectively. See full prescribing information for ARICEPT. ARICEPT (donepezil hydrochloride) tablets, for oral use ARICEPT ODT (donepezil hydrochloride) orally disintegra

Belviq xr extended release [eisai inc.]

These highlights do not include all the information needed to use BELVIQ XR safely and effectively . See full prescribing information for BELVIQ XR . BELVIQ XR (lorcaserin hydrochloride) extended - release   tablets for o ral u se , CIV Initial U.S. Appr

Rubraca [clovis oncology, inc.]

These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA.RUBRACA (rucaparib) tablets, for oral useInitial U.S. Approval: 2016

Carboplatin [sagent pharmaceuticals]

Carboplatin Injection(carboplatin aqueous solution)

Carboplatin [meitheal pharmaceuticals inc.]

Carboplatin Injection(carboplatin aqueous solution)

Carboplatin [hospira, inc.]

Carboplatin Injection

Carboplatin [ingenus pharmaceuticals, llc]

Carboplatin InjectionRx only

Carboplatin [cipla usa inc.]

CARBOplatin Injection(Aqueous Solution)Rx Only

Fludeoxyglucose f 18 [spectron mrc, llc]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection. See full prescribing information for Fludeoxyglucose F18 Injection. Initial U.S. Approval 1994

Carboplatin [sanja pharmaceuticals company]

CARBOPLATIN- carboplatin injection, solution

Calcium acetate [safecor health, llc]

Calcium Acetate Tablets, USP



Advertisement
Quick Search
Advertisement
Advertisement